We are live on ! Find out more
AMYT

Amryt Pharma plc American Depositary Shares
AMYT

Delisted

AMYT was delisted on the 11th of April, 2023.

Back to rankings

0 hedge funds and large institutions have $0 invested in Amryt Pharma plc American Depositary Shares in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 79 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 79 → 0 (-79)

100% less funds holding in top 10

Funds holding in top 10: 11 → 0 (-11)

100% less capital invested

Capital invested by funds: $720M → $0 (-$720M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 79

Holders
–
Holders Change
-79
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-11
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
79
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
ACM
Athyrium Capital Management
New York
-$129M
2
HCM
Highbridge Capital Management
New York
-$92.3M
3
SCM
Stonepine Capital Management
Oregon
-$91.5M
4
MAM
MPM Asset Management
Massachusetts
-$38.9M
5
Morgan Stanley
Morgan Stanley
New York
-$36.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
JC
51
JBF Capital
Colorado
– -$1.09M -75,000 Closed
VI
52
Vestcor Inc
New Brunswick, Canada
– -$1.02M -70,000 Closed
Arrowstreet Capital
53
Arrowstreet Capital
Massachusetts
– -$940K -64,483 Closed
Osaic Holdings
54
Osaic Holdings
Arizona
– -$794K -54,494 Closed
Ameriprise
55
Ameriprise
Minnesota
– -$657K -45,086 Closed
Geode Capital Management
56
Geode Capital Management
Massachusetts
– -$468K -32,094 Closed
UBS Group
57
UBS Group
Switzerland
– -$372K -25,540 Closed
HSBC Holdings
58
HSBC Holdings
United Kingdom
– -$366K -25,091 Closed
HF
59
HRT Financial
New York
– -$359K -24,675 Closed
BHMP
60
Bardin Hill Management Partners
New York
– -$294K -20,123 Closed
E
61
Ergoteles
New York
– -$291K -19,936 Closed
State Street
62
State Street
Massachusetts
– -$283K -19,376 Closed
VIA
63
Vident Investment Advisory
Georgia
– -$232K -15,912 Closed
OGC
64
One68 Global Capital
New York
– -$187K -12,815 Closed
Simplex Trading
65
Simplex Trading
Illinois
– -$164K -11,282 Closed
TI
66
Trexquant Investment
Connecticut
– -$152K -10,446 Closed
SOS
67
Silver Oak Securities
Tennessee
– -$152K -10,431 Closed
JP Morgan Chase
68
JP Morgan Chase
New York
– -$45K -3,073 Closed
Royal Bank of Canada
69
Royal Bank of Canada
Ontario, Canada
– -$25K -1,732 Closed
JEST
70
JTC Employer Solutions Trustee
Jersey
– -$17K -1,188 Closed
BSC
71
Brown Shipley & Co
United Kingdom
– -$4.55K -312 Closed
AA
72
Ancora Advisors
Ohio
– -$3.24K -222 Closed
FWM
73
Focused Wealth Management
New York
– -$2.74K -188 Closed
BTI
74
Blue Trust Inc
Georgia
– -$1K -170 Closed
AF
75
Allworth Financial
California
– -$2.3K -158 Closed
1 2
3
4

AMYT Hedge Fund Activity: Q2 2023 in Review

0 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Amryt Pharma plc American Depositary Shares (AMYT) for Q2 2023, worth a combined $0 — down 100% from $720M a quarter earlier.

Sellers outnumbered buyers: 79 funds closed out of AMYT and 0 opened new positions — a net loss of 79 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Athyrium Capital Management, exiting entirely with an estimated $129M sold.

  • 0 institutional investors held Amryt Pharma plc American Depositary Shares (AMYT) as of Q2 2023, down from 79 in Q1 2023.
  • Funds reported $0 of Amryt Pharma plc American Depositary Shares stock for Q2 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Amryt Pharma plc American Depositary Shares positions in Q2 2023 and 79 closed out, a net change of -79 holders.
  • The largest Amryt Pharma plc American Depositary Shares seller in Q2 2023 was Athyrium Capital Management, an estimated $129M sold.

Based on aggregated 13F filings for Q2 2023.